Our Mission

  • Provide input in the developement of novel compounds for the treatment of lymphoma
  • Review of clinical trial outlines
  • Develope early clinical „investigator initiated trials“
  • Provide a network of experienced and well equiped academical centers to facilitate rapid performance
  • Identify promising concepts for upcoming phase III trials of national and international disease networks